InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Fonseca Lidia, Chairman & CEO. Insider active across 2 companies, notably TEGNA INC. Aggregated, 4 disclosures have been published. The latest transaction was filed on 31 January 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
€315,6006,680 shares@ €47.24550.0002% mcap50.0% of flow
Common Stock
SEC:0001225208-22-001256:0·
€315,6006,680 shares@ €47.24550.0002% mcap100.0% of flow
Common Stock
SEC:0001225208-22-001256·
10,410 shares
Common Stock
SEC:0001214659-21-004902·
10,410 shares
Common Stock
SEC:0001214659-21-004902:0·
4 of 4 declarations
About Fonseca Lidia
Lidia Fonseca is the CEO & Executive Vice President at TEGNA INC and Pfizer Inc. She oversees the strategic and business operations of both companies, focusing on innovation and growth. Her role is crucial for developing new initiatives and optimizing TEGNA and Pfizer's performance in their respective sectors.
